Type of vaccine: mRNA vaccine |
Adults (≥18 years) | Pfizer/BioNTech Ages: 12 years and older (gray cap or purple cap) | Primary 2 doses (30 μg [0.3 mL] each [purple or gray cap])Separate: Dose 1 and 2 by at least 3-8 weeks.c | Booster Dose 1: At least 5 months after Dose 2 (30 μg [0.3 mL]).Booster Dose 2: At least 4 months after the first booster dose (30 μg [0.3 mL]) for individuals 50 years of age and older. | Primary 3 doses. Separate: Dose 1 and 2 by at least 3 weeks. Dose 2 and 3 by at least 4 weeks. | Booster Dose 1: At least 3 months after Dose 3Booster Dose 2: At least 4 months after the first booster (optional) |
Moderna | Primary 2 doses (100 μg [0.5 mL] each [blue cap]).c Separate: Dose 1 and 2 by at least 4-8 weeks. | Booster Dose 1: At least 5 months after Dose 2 (50 μg [0.25 mL] [red cap]).Booster Dose 2: At least 4 months after the first booster dose (50 μg [0.25 mL]). | Primary 3 doses. Separate: Dose 1 and 2 by at least 4 weeks. Dose 2 and 3 by at least 4 weeks. | Booster Dose 1: At least 3 months after Dose 3Booster Dose 2: At least 4 months after the first booster dose (optional) |
Adolescents (12-17 years) | Pfizer/BioNTech Ages: 12 years and older (gray cap or purple cap) | Primary 2 doses (30 μg [0.3 mL] each [purple or gray cap]). Separate: Dose 1 and 2 by at least 3-8 weeks.c | Booster Dose 1: At least 5 months after Dose 2 (30 μg [0.3 mL]).Booster Dose 2: At least 4 months after the first booster dose (30 μg [0.3 mL]) | Primary 3 doses (30 μg [0.3 mL] each). Separate: Dose 1 and 2 by at least 3 weeks. Dose 2 and 3 by at least 4 weeks. | Booster Dose 1: At least 3 months after Dose 3Booster Dose 2: At least 4 months after the first booster dose (optional) |
Moderna | Not recommended | Not recommended | Not recommended | Not recommended |
Children (5-11 years) | Pfizer/BioNTech Ages: 5-11 years (Orange cap) | Primary 2 doses (10 μg [0.2 mL] each [orange cap]). Separate: Dose 1 and 2 by at least 3 weeks | Not recommended | Primary 3 doses. Separate: Dose 1 and 2 by at least 3 weeks. Dose 2 and 3 by at least 4 weeks. | Not recommended |
Young children (6 months -4 years) | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Infants (<2 years) | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Pregnant women | Pfizer/BioNTech | Primary 2 doses (30 μg [0.3 mL] each [purple or gray cap]) Separate: Dose 1 and 2 by at least 3-8 weeks. | Booster Dose 1: At least 5 months after Dose 2 (30 μg [0.3 mL]). | Not applicable | Not applicable |
Moderna | Primary 2 doses (100 μg [0.5 mL] each [blue cap]). Separate: Dose 1 and 2 by at least 4-8 weeks. | Booster Dose 1: At least 5 months after Dose 2 (50 μg [0.25 mL]). | Not applicable | Not applicable |
Lactating women | Pfizer/BioNTech | Primary 2 doses (30 μg [0.3 mL] each [purple or gray cap]) Separate: Dose 1 and 2 by at least 3-8 weeks. | Booster Dose 1: At least 5 months after Dose 2 (30 μg [0.3 mL]). | Not applicable | Not applicable |
Moderna | Primary 2 doses (100 μg [0.5 mL] each [blue cap]). Separate: Dose 1 and 2 by at least 4-8 weeks. | Booster Dose 1: At least 5 months after Dose 2 (50 μg [0.25 mL]). | Not applicable | Not applicable |
Type of vaccine: Viral vector vaccine |
Adults (≥18 years) | Janssend | Primary 1 dose (5 × 1010 viral particles [0.5 mL]).b | Booster Dose 1: At least 8 weeks after Dose 1 (5 × 1010 viral particles/mL [0.5 mL]).d | Primary 2 doses (5 × 1010 viral particles/mL [0.5 mL]). Separate: Dose 1 and 2 by at least 28 daysd Dose 2 MUST be a mRNA vaccine.d | Booster Dose 1: At least 8 weeks after Dose 2 (5 × 1010 viral particles/mL [0.5 mL]).d |
Future plan |
Young children (6 months -4 years) | Pfizer/BioNTech Ages: 6 months -4 years (Maroon cap) | Primary 2 doses (3 μg [0.2 mL] each [maroon cap]). Separate: Dose 1 and 2 by at least 3 weeks | Not recommended | Primary 3 doses. Separate: Dose 1 and 2 by at least 3 weeks. Dose 2 and 3 by at least 4 weeks. | Not recommended |